Search scope:
排序: Display mode:
Frontiers of Medicine doi: 10.1007/s11684-023-1029-3
Keywords: tumor prognosis molecular Microbiome subsets determine center analysis microbiome transcriptome data
JIANG Yuan, TIAN Xuehong, YUAN Jie, JIN Yuemei, TAN Yusong
Frontiers of Medicine 2007, Volume 1, Issue 4, Pages 398-400 doi: 10.1007/s11684-007-0077-4
Keywords: anticarcinogenic microvessel density malignant potency muscle uterine leiomyosarcoma
Frontiers of Medicine doi: 10.1007/s11684-023-1050-6
Keywords: pancreatic cancer cancer screening single cell molecular alterations precancerous lesion therapy
Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu
Frontiers of Medicine 2016, Volume 10, Issue 1, Pages 33-40 doi: 10.1007/s11684-016-0431-5
Breast cancer is the most common malignant tumor in women, and the incidence of this disease has increasedCancer-associated fibroblasts (CAFs), the most abundant cells in tumor stroma, secrete various activeinvasion, and metastasis of cancer but also serve as biomarkers in the clinical diagnosis, therapy, and prognosis
Keywords: cancer-associated fibroblast breast cancer progression prognosis
Tumor Molecular Imaging with Nanoparticles Review
Zhen Cheng,Xuefeng Yan,Xilin Sun,Baozhong Shen,Sanjiv Sam Gambhir
Engineering 2016, Volume 2, Issue 1, Pages 132-140 doi: 10.1016/J.ENG.2016.01.027
Molecular imaging (MI) can provide not only structural images using traditional imaging techniquesbut also functional and molecular information using many newly emerging imaging techniques.It is expected that multimodality nanoparticles (NPs) can lead to precise assessment of tumor biologyand the tumor microenvironment.
Keywords: Tumor Molecular imaging Nanoparticles
Caveolin proteins: a molecular insight into disease
Hongli Yin,Tianyi Liu,Ying Zhang,Baofeng Yang
Frontiers of Medicine 2016, Volume 10, Issue 4, Pages 397-404 doi: 10.1007/s11684-016-0483-6
Keywords: caveolin caveolae microRNA disease signaling pathway heart tumor
Translational medicine in hepatocellular carcinoma
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 122-133 doi: 10.1007/s11684-012-0193-7
Keywords: hepatocellular carcinoma molecular classification molecular targeted therapies tumor microenvironment
Zhi Xu,Chunxiang Cao,Haiyan Xia,Shujing Shi,Lingzhi Hong,Xiaowei Wei,Dongying Gu,Jianmin Bian,Zijun Liu,Wenbin Huang,Yixin Zhang,Song He,Nikki Pui-Yue Lee,Jinfei Chen
Frontiers of Medicine 2016, Volume 10, Issue 1, Pages 52-60 doi: 10.1007/s11684-016-0433-3
Hepatocellular carcinoma (HCC) is a lethal liver malignancy worldwide. In this study, we reported that protein phosphatase magnesium-dependent 1δ (PPM1D) was highly expressed in the majority of HCC cases (approximately 59%) and significantly associated with high serum α-fetoprotein (AFP) level (P= 0.044). Kaplan-Meier and Cox regression data indicated that PPM1D overexpression was an independent predictor of HCC-specific overall survival (HR, 2.799; 95% CI, 1.346–5.818, P = 0.006). Overexpressing PPM1D promoted cell viability and invasion, whereas RNA interference-mediated knockdown of PPM1D inhibited proliferation, invasion, and migration of cultured HCC cells. In addition, PPM1D suppression by small interfering RNA decreased the tumorigenicity of HCC cells in vivo. Overall, results suggest that PPM1D is a potential prognostic marker and therapeutic target for HCC.
Keywords: PPM1D hepatocellular carcinoma prognosis target therapy
Jiangtao YAN, Rutai HUI, Daowen WANG
Frontiers of Medicine 2009, Volume 3, Issue 1, Pages 30-35 doi: 10.1007/s11684-009-0005-x
Keywords: C-reactive protein inflammation stroke
Risk factors of prognosis after acute kidney injury in hospitalized patients
Sasa Nie, Zhe Feng, Lihua Xia, Jiuxu Bai, Fenglin Xiao, Jian Liu, Li Tang, Xiangmei Chen
Frontiers of Medicine 2017, Volume 11, Issue 3, Pages 393-402 doi: 10.1007/s11684-017-0532-9
The risk factors, especially laboratory indicators, of prognosis after acute kidney injury (AKI) remainIncreased AKI stage, tumor disease, post-cardiopulmonary resuscitation, and RRT were the risk factors
Keywords: acute kidney injury risk factors prognosis
Heterogeneity of the tumor immune microenvironment and clinical interventions
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 617-648 doi: 10.1007/s11684-023-1015-9
Keywords: Heterogeneity tumor immune
Proteins moonlighting in tumor metabolism and epigenetics
Lei Lv, Qunying Lei
Frontiers of Medicine 2021, Volume 15, Issue 3, Pages 383-403 doi: 10.1007/s11684-020-0818-1
Keywords: moonlighting function tumor metabolism epigenetics
Complex interplay between tumor microenvironment and cancer therapy
Minhong Shen, Yibin Kang
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 426-439 doi: 10.1007/s11684-018-0663-7
Tumor microenvironment (TME) is comprised of cellular and non-cellular components that exist withinand around the tumor mass.Given the importance of TME in tumor progression and therapy resistance, strategies that remodel TME
Keywords: tumor microenvironment therapy response treatment resistance
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 699-713 doi: 10.1007/s11684-022-0972-8
Keywords: anti-CD19 chimeric antigen receptor T immunotherapy diffuse large B cell lymphoma tumor microenvironment tumor-associated macrophage metabolism
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
Bingxue Shang, Zhifei Cao, Quansheng Zhou
Frontiers of Medicine 2012, Volume 6, Issue 1, Pages 67-78 doi: 10.1007/s11684-012-0176-8
Keywords: angiogenesis vasculogenesis neovascularization tumor vasculature normalization traditional Chinese medicine
Title Author Date Type Operation
Microbiome subsets determine tumor prognosis and molecular characteristics of clear-cell renal cell carcinoma
Journal Article
Relationship of adrenomedullin expression and microvessel density and prognosis in smooth muscle tumor
JIANG Yuan, TIAN Xuehong, YUAN Jie, JIN Yuemei, TAN Yusong
Journal Article
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic
Journal Article
Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications
Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu
Journal Article
Tumor Molecular Imaging with Nanoparticles
Zhen Cheng,Xuefeng Yan,Xilin Sun,Baozhong Shen,Sanjiv Sam Gambhir
Journal Article
Caveolin proteins: a molecular insight into disease
Hongli Yin,Tianyi Liu,Ying Zhang,Baofeng Yang
Journal Article
Translational medicine in hepatocellular carcinoma
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan
Journal Article
Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma
Zhi Xu,Chunxiang Cao,Haiyan Xia,Shujing Shi,Lingzhi Hong,Xiaowei Wei,Dongying Gu,Jianmin Bian,Zijun Liu,Wenbin Huang,Yixin Zhang,Song He,Nikki Pui-Yue Lee,Jinfei Chen
Journal Article
Elevated C-reactive protein levels predict worsening prognosis in Chinese patients with first-onset stroke
Jiangtao YAN, Rutai HUI, Daowen WANG
Journal Article
Risk factors of prognosis after acute kidney injury in hospitalized patients
Sasa Nie, Zhe Feng, Lihua Xia, Jiuxu Bai, Fenglin Xiao, Jian Liu, Li Tang, Xiangmei Chen
Journal Article
Complex interplay between tumor microenvironment and cancer therapy
Minhong Shen, Yibin Kang
Journal Article
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma
Journal Article